Pentoxifylline Injection (Aoting) 0.1g/5ml × 6 Vials

Pentoxifylline Injection (Aoting) 0.1g/5ml × 6 Vials

$2.00

Pentoxifylline Injection (Aoting) is a research-grade methylxanthine derivative used in blood flow and ischemic tissue studies. Each 5ml vial contains 100mg of pentoxifylline. Supplied in packs of 6 vials. For laboratory use only.?Please consult staff for price, other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare
Category:

Description

Pentoxifylline is a xanthine derivative that improves microcirculation by increasing erythrocyte flexibility and reducing blood viscosity. It also exhibits anti-inflammatory and antithrombotic effects, making it valuable in preclinical research involving vascular, inflammatory, and ischemic models.

Pentoxifylline Injection (Aoting) delivers 0.1g (100mg) of active compound per 5ml vial, with 6 vials per box. This injectable formulation is used in animal studies and in vitro research focusing on tissue perfusion, inflammatory cytokine modulation, and vascular reactivity.

Manufactured by Harbin Sanlian Pharmaceutical Co., Ltd., and approved by China’s NMPA under registration number H200330670, with product code 86903662001555.

For laboratory research use only. Not intended for human or veterinary applications.


Product Specifications

ParameterDetails
Product NamePentoxifylline Injection (Aoting)
Generic NamePentoxifylline
CAS Number6493-05-6
Molecular FormulaC13H18N4O3
Molecular Weight278.31 g/mol
Dosage FormInjection
Strength0.1g (100mg) per 5ml
Quantity6 vials per box
Approval NumberH200330670 (China NMPA)
Product Code86903662001555
ManufacturerHarbin Sanlian Pharmaceutical Co., Ltd.
BarcodeNot provided
Intended UseLaboratory research only
Storage ConditionsStore in a cool, dry place below 25°C; protect from light

Mechanism & Research Applications

Pentoxifylline works primarily by increasing red blood cell deformability, decreasing blood viscosity, and inhibiting platelet aggregation. It improves peripheral blood flow and has anti-inflammatory and immunomodulatory properties.

This compound is widely used in research focused on:

  • Peripheral vascular disease and ischemia

  • Diabetic microangiopathy models

  • Tumor perfusion and oxygenation studies

  • Cytokine modulation and inflammation

  • Stroke and cerebral ischemia recovery models


Safety & Handling

Use Restriction: For laboratory research only. Not for clinical, therapeutic, or diagnostic use.
Personal Protection: Wear gloves, lab coat, and safety goggles when handling.
Reconstitution: Ready-to-use injectable. Use under sterile lab conditions.
Storage: Keep sealed below 25°C; avoid direct sunlight.
Disposal: Dispose of in accordance with local chemical and biohazard waste regulations.


Research Use Disclaimer

This product is designated exclusively for laboratory research. It is not approved for use in clinical, diagnostic, or veterinary settings. Misuse may carry legal and safety consequences. Always follow local biosafety and ethical research protocols.

Additional information

Weight1 kg
Dimensions26 × 23 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Pentoxifylline Injection (Aoting) 0.1g/5ml × 6 Vials”

Your email address will not be published. Required fields are marked *

Q1: Is this product safe for human injection?

A1: No. This is for laboratory use only and not approved for clinical or diagnostic use in humans or animals.

Q2: Can I buy in large quantities?

A2: Yes. We support both wholesale and retail orders with flexible shipping and pricing.

Q3: Are COA and SDS available?

A3: Yes. Certificates of Analysis (COA) and Safety Data Sheets (SDS) are available upon request.

Q4: What are typical research applications?

A4: Studies involving microcirculation, vascular inflammation, ischemic injury, and blood rheology.

Q5: What is the packaging format?

A5: Each box contains 6 vials, each with 0.1g pentoxifylline in 5ml solution.


EMI Options

Select at least 2 products
to compare